As p-tau217 was the most significant AD-associated protein, we analyzed its biomarker performance in the context of AD-related phenotypes such as Amyloid-PET, Tau-PET, Aβ42/40 ratio and CDR. This evidence concerns the gene MAPT and Alzheimer disease.